Abstract:Epigenetics encompasses reversible and heritable chemical modifications of non-nuclear DNA sequences, including DNA and RNA methylation, histone modifications, non-coding RNA modifications, and chromatin rearrangements. In addition to well-studied DNA and histone methylation, RNA methylation has emerged as a hot topic in biological sciences over the past decade. N6-methyladenosine (m6A) is the most common and abundant modification in eukaryotic mRNA, affecting all RNA stages, including transcription, translation, and degradation. Advances in high-throughput sequencing technologies made it feasible to identify the chemical basis and biological functions of m6A RNA. Dysregulation of m6A levels and associated modifying proteins can both inhibit and promote cancer, highlighting the importance of the tumor microenvironment in diverse biological processes. Gastrointestinal tract cancers, including gastric, colorectal, and pancreatic cancers, are among the most common and deadly malignancies in humans. Growing evidence suggests a close association between m6A levels and the progression of gastrointestinal tumors. Global m6A modification levels are substantially modified in gastrointestinal tumor tissues and cell lines compared to healthy tissues and cells, possibly influencing various biological behaviors such as tumor cell proliferation, invasion, metastasis, and drug resistance. Exploring the diagnostic and therapeutic potential of m6A-related proteins is critical from a clinical standpoint. Developing more specific and effective m6A modulators offers new options for treating these tumors and deeper insights into gastrointestinal tract cancers.

The N6-Methyladenosine Modification and Its Role in Mrna Metabolism and Gastrointestinal Tract Disease

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Interaction Between N6-methyladenosine Modification and the Tumor Microenvironment in Colorectal Cancer

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

Function of N6-Methyladenosine Modification in Tumors

The Roles of M6a RNA Modifiers in Human Cancer

Roles and Implications of Mrna N6 -Methyladenosine in Cancer.

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

Current researches on N6-methyladenosine and its functions in solid tumors

RNA M6a Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications.

Roles and implications of mRNA N 6 ‐methyladenosine in cancer

Mechanisms and clinical landscape of N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers

The potential role of RNA N6-methyladenosine in Cancer progression

Mechanisms of N6‑methyladenosine Modification in Tumor Development and Potential Therapeutic Strategies (Review)

The Evolving Landscape of N6-methyladenosine Modification in the Tumor Microenvironment.

N6-methyladenosine modification: a novel pharmacological target for anti-cancer drug development

The Roles of N6-methyladenosine and Its Target Regulatory Noncoding RNAs in Tumors: Classification, Mechanisms, and Potential Therapeutic Implications.

The Potential Roles of RNA N6-Methyladenosine in Urological Tumors